SmartNuclide

News

PRODUCTS

We are committed to the development, production, and commercialization of diagnostic and therapeutic drugs in the field of nuclear medicine
Company News Media News

Suzhou SmartNuclide Biopharma to Present First-in-Human Clinical Trial Data for [68Ga]Ga-SNA014 at 2025 SNMMI Annual Meeting2025年6月17日

June 2025, Suzhou – Suzhou SmartNuclide Biopharma Co., […]

SmartNuclide Biopharma Co., Ltd. Announces Multiple Presentations at 2025 EANM Annual Congress2025年9月23日

Recently, multiple innovative research achievements fro […]